Novo Nordisk (NVO) Launches Wegovy Pill in UAE, First Outside U.S.

AI Summary

Novo Nordisk (NVO) is launching its weight loss pill Wegovy in the UAE, marking its first international launch beyond the U.S. This decision is influenced by factors such as patient demand and the healthcare infrastructure in the UAE, as stated by Emil Kongshøj Larsen, executive vice president of International Operations. The company indicated plans to expand Wegovy into additional select countries in the future. This move could signify a strategic expansion in global markets for Novo Nordisk.